WO1999033973A3 - Cellules clonees produisant un recepteur d'octopamine - Google Patents
Cellules clonees produisant un recepteur d'octopamine Download PDFInfo
- Publication number
- WO1999033973A3 WO1999033973A3 PCT/EP1998/008411 EP9808411W WO9933973A3 WO 1999033973 A3 WO1999033973 A3 WO 1999033973A3 EP 9808411 W EP9808411 W EP 9808411W WO 9933973 A3 WO9933973 A3 WO 9933973A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- receptor
- neurotransmitter
- cells
- producing cells
- octapamine
- Prior art date
Links
- 108090000590 Neurotransmitter Receptors Proteins 0.000 abstract 4
- 102000004108 Neurotransmitter Receptors Human genes 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108010003516 norsynephrine receptor Proteins 0.000 abstract 2
- 238000010367 cloning Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000010473 stable expression Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
L'invention concerne un procédé permettant de préparer des cellules produisant un récepteur d'octopamine. A cette fin, au moins un gène codant un récepteur d'octopamine est transformé en cellule hôte. Le clonage de gènes récepteurs à neuromédiateurs et leur expression stable permettent d'examiner, pour la première fois, des sous-types définis de récepteurs à neuromédiateurs. Les cellules transformées par le gène récepteur à neuromédiateurs s'utilisent dans le cadre d'un procédé simple d'examen des propriétés de récepteurs à neuromédiateurs. Selon ce procédé, on fait agir un ligand à examiner sur ces cellules et l'effet produit est déterminé par analyse des substances messagères intracellulaires.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19757695.8 | 1997-12-23 | ||
| DE1997157695 DE19757695A1 (de) | 1997-12-23 | 1997-12-23 | Klonierte, Neurotransmitter-Rezeptor produzierende Zellen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1999033973A2 WO1999033973A2 (fr) | 1999-07-08 |
| WO1999033973A3 true WO1999033973A3 (fr) | 1999-09-16 |
Family
ID=7853269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP1998/008411 WO1999033973A2 (fr) | 1997-12-23 | 1998-12-22 | Cellules clonees produisant un recepteur d'octopamine |
Country Status (2)
| Country | Link |
|---|---|
| DE (2) | DE19758545A1 (fr) |
| WO (1) | WO1999033973A2 (fr) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7541155B2 (en) | 2003-04-24 | 2009-06-02 | Tyratech, Inc. | Methods of screening compositions for potential insect control activity |
| US7622269B2 (en) | 2004-03-19 | 2009-11-24 | Tyratech, Inc. | Methods of screening tyramine- and octopamine-expressing cells for compounds and compositions having potential insect control activity |
| US8685471B2 (en) | 2006-07-17 | 2014-04-01 | Tyratech, Inc. | Compositions and methods for controlling insects |
| US8865230B2 (en) | 2006-06-27 | 2014-10-21 | Tyratech, Inc. | Compositions and methods for treating parasitic infections |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10150971B8 (de) * | 2001-10-05 | 2006-11-09 | Technische Universität Dresden | Verfahren und Vorrichtung zur Messung der Rezeptoraktivität an transfizierten Zellen |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5344776A (en) * | 1991-03-28 | 1994-09-06 | The United States Of America As Represented By The Department Of Health And Human Services | DNA encoding an insect octopamine receptor |
| WO1999021891A1 (fr) * | 1997-10-27 | 1999-05-06 | Baylor College Of Medicine | Recepteur d'octopamine d'invertebres |
-
1997
- 1997-12-23 DE DE19758545A patent/DE19758545A1/de not_active Withdrawn
- 1997-12-23 DE DE1997157695 patent/DE19757695A1/de not_active Withdrawn
-
1998
- 1998-12-22 WO PCT/EP1998/008411 patent/WO1999033973A2/fr not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5344776A (en) * | 1991-03-28 | 1994-09-06 | The United States Of America As Represented By The Department Of Health And Human Services | DNA encoding an insect octopamine receptor |
| WO1999021891A1 (fr) * | 1997-10-27 | 1999-05-06 | Baylor College Of Medicine | Recepteur d'octopamine d'invertebres |
Non-Patent Citations (3)
| Title |
|---|
| EVANS P.D. , ROBB S.: "Octopamine Receptor Subtypes and Their Modes of Action", NEUROCHEMICAL RESEARCH, vol. 18, no. 8, August 1993 (1993-08-01), pages 869 - 874, XP002109582 * |
| GERHARDT C.C. ET AL.: "Cloning and Expression of a Complementary DNA Encoding a Molluscan Octopamine Receptor That Couples to Chloride Channels in HEK293 Cells", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 10, 7 March 1997 (1997-03-07), pages 6201 - 6207, XP002109580 * |
| HAN K.A. ET AL.: "Novel biogenic amine receptors preferentially expressed in mushroom bodies of Drosophila melanogaster", SOCIETY FOR NEUROSCIENCE ABSTRACTS; 27TH ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE NEW ORLEANS, LOUISIANA, USA, 25-30 OF OCTOBER, 1997, vol. 23, no. 1-2, pages 1417, XP002109581 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7541155B2 (en) | 2003-04-24 | 2009-06-02 | Tyratech, Inc. | Methods of screening compositions for potential insect control activity |
| US8507013B2 (en) | 2003-04-24 | 2013-08-13 | Tyratech, Inc. | Compositions for controlling insects |
| US7622269B2 (en) | 2004-03-19 | 2009-11-24 | Tyratech, Inc. | Methods of screening tyramine- and octopamine-expressing cells for compounds and compositions having potential insect control activity |
| US8865230B2 (en) | 2006-06-27 | 2014-10-21 | Tyratech, Inc. | Compositions and methods for treating parasitic infections |
| US8685471B2 (en) | 2006-07-17 | 2014-04-01 | Tyratech, Inc. | Compositions and methods for controlling insects |
Also Published As
| Publication number | Publication date |
|---|---|
| DE19757695A1 (de) | 1999-07-01 |
| WO1999033973A2 (fr) | 1999-07-08 |
| DE19758545A1 (de) | 1999-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wisden et al. | The cerebellum: a model system for studying GABAA receptor diversity | |
| WO2000012704A3 (fr) | Expression fonctionnelle amelioree des recepteurs couples a la proteine g | |
| NO20014813D0 (no) | Fremgangsmåte for fremstilling av syntetisk naftadrivstoff og syntetisk naftadrivstoff fremstilt ved fremgangsmåten | |
| Laubie et al. | Pharmacological properties of (N-dicyclopropylmethyl) amino-2-oxazoline (S 3341), an alpha-2 adrenoceptor agonist. | |
| AU2002233225A1 (en) | Bioanalytical reagent, method for production thereof, sensor platforms and detection methods based on use of said bioanalytical reagent | |
| CA2087614A1 (fr) | Methodes pour caracteriser des composes qui agissent comme agonistes ou antagonistes pour les proteines intervenant dans la transduction de signaux | |
| WO1999033973A3 (fr) | Cellules clonees produisant un recepteur d'octopamine | |
| ATE285472T1 (de) | Glucagonrezeptoren | |
| WO2001098330A3 (fr) | Lignee cellulaire recombinee exprimant gpcrx11 en tant que recepteur fonctionnel valide par l'angiopeptine et utile dans le criblage d'agonistes et antagonistes | |
| Aicardi et al. | Noradrenergic inhibition and voltage‐dependent facilitation of ω‐conotoxin‐sensitive Ca channels in insulin‐secreting RINm5F cells | |
| AUPN646795A0 (en) | Neuropeptide Y-Y5 receptor | |
| Main et al. | The CGRP receptor can couple via pertussis toxin sensitive and insensitive G proteins | |
| Allegrini et al. | A dynamical approach to DNA sequences | |
| Cuypers et al. | A stochastic cracking theory for the introduction of matrix multiple cracking in textile reinforced concrete under tensile loading | |
| Petrov et al. | On hadron multiplicity in e+ e− events induced by massive quarks | |
| Dovers et al. | Australian rivers and statute law | |
| EP0892046A3 (fr) | Cellules exprimant le récepteur de melatonine et leurs applications | |
| CA2120604A1 (fr) | Methode d'evaluation in vitro des effets d'une substance | |
| Spedding et al. | International Union of Pharmacology. XXXI. Recommendations for the nomenclature of multimeric G protein-coupled receptors | |
| WO1998054223A3 (fr) | Procede d'immunologie | |
| Obrochta et al. | Mid Pleistocene Age for the Great Barrier Reef | |
| Allen et al. | Chronic disease:# 22 Does increase in blood pressure predict increase in urinary albumin excretion rate in the first 9 years of type 1 diabetes? | |
| Monczor et al. | Tiotidine, a classical H2-antagonist, presents characteristics of an inverse agonist in U937 cell line | |
| Sawyer et al. | Sediment Shear Strength Properties within the Hydrate Stability Zone: Results from the Gulf of Mexico Deepwater Hydrate Coring Expedition, Terrebonne Basin, Gulf of Mexico | |
| WO2003023361A3 (fr) | Distinction d'agonistes, d'antagonistes et d'agonistes inverses par resonance guides d'ondes du plasmon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| WA | Withdrawal of international application |